Can the New PACS Viewer Bolster Efficiency in Radiology Workflows?
The newly FDA-cleared PACS Viewer from CliniComp reportedly allows direct review and analysis of imaging within a patient’s chart.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the PACS Viewer, which may facilitate improved access to quality imaging scans, patient data and AI tools within one platform.
CliniComp, the manufacturer of the
The company noted that other pertinent features of the PACS Viewer include:
• correlation of imaging with relevant clinical history, medications and laboratory results;
• embedding of AI-powered documentation; and
• automated triage of high-acuity studies.
“Healthcare organizations have spent decades managing separate clinical, imaging, and administrative systems," said Chris Haudenschild, the CEO of CliniComp. “With FDA clearance of our PACS Viewer, we're extending our unified EHR strategy to enterprise imaging, allowing clinicians to access diagnostic-quality imaging, advanced image processing, patient data, and native AI capabilities from a single platform. This creates a more integrated and connected enterprise experience for providers and a stronger foundation for patient care.”
Related Content
